Search

everythinglearnresearchcommunity

for

Search:↓

Stress hormones and autoimmune reactions can cause hair loss.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Trichloroethylene causes skin inflammation in mice by increasing certain immune proteins.

The review suggests that a special cell-derived treatment shows promise for various skin conditions and hair growth but needs more research for confirmation.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

PPARγ is essential for maintaining healthy skin, controlling inflammation, and ensuring proper skin barrier function.

Skin cells release substances important for healing and fighting infection, and understanding these could improve skin disorder treatments.

Ceramide Synthase 4 is crucial for maintaining hair follicle stem cells and preventing hair loss.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Bioprinting is improving skin models for better testing of skin diseases without using animals.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Type 3 Innate Lymphoid Cells help maintain skin health and balance, and are involved in skin diseases and healing.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.

Justicia procumbens extract may help prevent hair loss and improve hair thickness and shine in a type of hair loss condition.

TNF-alpha inhibitors can cause various immune-related skin issues.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Prostaglandin D2 blocks new hair growth after skin injury through the Gpr44 receptor.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Upadacitinib improved multiple immune-related conditions in one patient.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Aging reduces skin cell renewal and defense against germs due to TGFbeta, but blocking TGFbeta could help restore these functions.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Testosterone may slow down wound healing and increase inflammation.